Philadelphia, PA, (6 Feb, 2012) Greenphire announced today that it has formed an exclusive strategic partnership with the clinical trials division of Merge Healthcare (NASDAQ: MRGE), a leading provider of clinical trial solutions, to offer integrated functionality between Merge’s EDC technology and Greenphire’s eClinicalGPS site and vendor payment management technology. The integrated EDC and payment technology offering will enable both companies’ pharmaceutical, medical device, and CRO clients to further automate and centrally track all clinical payments on a global basis.
“Our alliance with Merge enables us to collaboratively bring an innovative and complementary set of technologies to the clinical research industry, driving additional efficiency to sponsors, CROs and sites on a global basis,” said Greenphire CEO Sam Whitaker. “Our integrated functionality with Merge adds value to existing Merge and Greenphire clients, and offers operational efficiencies which our industry has never achieved previously.”
The functionality achieved through this strategic partnership will streamline implementation processes and create additional efficiencies for clients, enabling users to automate research site and clinical vendor payments in local currency through Greenphire’s centralized, global web-based payment engine. It will also streamline setup times, decrease sponsor, site and CRO administrative burdens on an on-going basis, reduce payment administration costs and timelines, and increase site satisfaction. Additionally, centrally automating global clinical payments will significantly reduce costs for both sponsors and CROs by electronically automating what have historically been multi-step and manual payment administration processes.
“This partnership demonstrates that Merge is committed to addressing the needs of our clinical trials customers, specifically those who have asked for an integrated site payment system for their clinical programs,” said Jeff Surges, CEO of Merge Healthcare. “We’re looking forward to working with Greenphire and to improving workflow processes and efficiencies for our clients.” To date, Merge is already using the integrated functionality to execute three unique projects, with several more planned for 2012.
For further information on Greenphire and its innovative solutions please email: sales@greenphire.com, call +1 215-609-4640 or visit www.greenphire.com
About Greenphire
Greenphire is a clinical technology company, headquartered in suburban Philadelphia, that offers web-based clinical payment technology platforms to research sites, research universities, sponsors and CROs. Greenphire’s clinical payment technologies are designed to execute patient payments, site payments and vendor payments on a global basis, in local currency, utilizing a single web portal. Greenphire’s technologies are designed to streamline operations, reduce administration, reduce costs and provide analytics to users that have not be readily available in the past. Greenphire’s global patient payment technology also incorporates automated electronic messaging functionality that, when combined with payment functionality, effectively improves the clinical experience for patients and sites, drives positive patient behavior to increase patient retention and protocol compliance, and significantly reduces site and study team administration associated with patient payments and communication. Learn more about Greenphire’s innovative clinical solutions at www.greenphire.com.
About Merge Healthcare
Merge Healthcare is a leading provider of enterprise imaging and interoperability solutions. Merge solutions facilitate the sharing of images and data to create a more effective and efficient electronic healthcare experience for patients and physicians. Merge provides enterprise imaging solutions for radiology, cardiology, orthopaedics and eye care; a suite of products for clinical trials featuring Merge EDC, IVR/IWR, Merge ePRO, Merge CIMS, Merge EAS and Merge myEDC; software for financial and pre-surgical management, and applications that fuel the largest modality vendors in the world. Merge’s products have been used by healthcare providers, vendors and researchers worldwide to improve patient care for more than 20 years. Additional information can be found at www.merge.com.
For further press information please contact Celine Goodier, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email greenphire@scottpr.com
